Related Experiment Video
Updated: Jul 10, 2026

Generation of Stable Human Cell Lines with Tetracycline-inducible (Tet-on) shRNA or cDNA Expression
Published on: March 5, 2013
Multiple defects of cell cycle checkpoints in U937-ASPI3K, an U937 cell mutant stably expressing anti-sense ATM gene
1Department of Hematology, Tongji Hospital, Tongji Medical University, Wuhan 430030.
Abstract:
(Ataxia-telangiectasia mutated gene (ATM) functions in control of cell cycle checkpoints in responding to DNA damage and protects cells from undergoing apoptosis. Knock-out within tumor cells of endogenous ATM will achieve therapeutic benefits and enable a better understanding of the decisive mechanisms of cell death or survival in response to DNA damaging agents.) In present paper, we sought to characterize the cell cycle checkpoint profiles in U937-ASPI3K, a U937 cell mutant that was previously established with endogenous ATM knock-out phenotype. Synchronized U937-ASPI3K was exposed to 137Cs irradiation, G1, S, G2/M cell cycle checkpoint profiles were evaluated by determining cell cycle kinetics, p53/p21 protein, cyclin dependent kinase 2 (CDK2) and p34CDC2 kinase activity in response to irradiation. U937-ASPI3K exhibited multiple defects in cell cycle checkpoints as defined by failing to arrest cells upon irradiation. The accumulation of cellular p53/p21 protein and inhibition of CDK kinase was also abolished in U937-ASPI3K. It was concluded that the stable expression of anti-sense PI3K cDNA fragment completely abolished multiple cell cycle checkpoints in U937-ASPI3K, and hence U937-ASPI3K with an AT-like phenotype could serves as a valuable model system for investigating the signal transduction pathway in responding to DNA damaging-based cancer therapy.
Insights
Ataxia-telangiectasia mutated gene (ATM) knockout in U937-ASPI3K cells disrupted cell cycle checkpoints and DNA damage response. This ATM-deficient model offers insights into cancer therapy mechanisms.
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- The Ataxia-telangiectasia mutated (ATM) gene is crucial for cell cycle checkpoints and apoptosis in response to DNA damage.
- Targeting ATM in tumor cells may offer therapeutic benefits and elucidate cell death mechanisms.
Purpose of the Study:
- To characterize cell cycle checkpoint profiles in U937-ASPI3K cells with endogenous ATM knockout.
- To investigate the response of these cells to DNA damaging agents like 137Cs irradiation.
Main Methods:
- U937-ASPI3K cells with ATM knockout were synchronized and exposed to 137Cs irradiation.
- Cell cycle kinetics, p53/p21 protein levels, and kinase activity (CDK2, p34CDC2) were assessed.
Main Results:
- U937-ASPI3K cells showed multiple defects in cell cycle checkpoints, failing to arrest upon irradiation.
- The accumulation of p53/p21 protein and inhibition of CDK kinase activity were abolished in these cells.
Conclusions:
- Stable expression of anti-sense PI3K cDNA in U937-ASPI3K cells completely abolished multiple cell cycle checkpoints.
- This ATM-deficient cell line serves as a valuable model for studying DNA damage response pathways in cancer therapy.
More Related Videos
12:02Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers
Published on: September 26, 2019
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Positive Regulator Molecules
Inhibition of Cdk Activity
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...